文献速递肝病消化道出血

8毫米覆膜TIPS不损害分流道功能且减少肝性脑病以预防静脉曲张再出血

Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
PubMed 文献 · J Hepatol · 2017-05-12

该随机对照研究将肝硬化患者分配至8毫米或10毫米覆膜支架TIPS以预防静脉曲张再出血,主要终点为分流道功能障碍。两组分流道功能障碍率、再出血率、无肝移植生存率及复合终点均无统计学差异,但8毫米组两年内自发性显性肝性脑病发生率显著更低(27% vs 43%,p=0.03),且肝脏功能损害更轻。作者认为8毫米TIPS支架应优先用于肝硬化患者静脉曲张再出血的预防。

要点

  • 8毫米与10毫米覆膜支架TIPS两年分流道功能障碍率均为16%(p=0.62),无统计学差异。
  • 8毫米组两年自发性显性肝性脑病发生率为27%,10毫米组为43%(p=0.03),风险降低47%。
  • 8毫米组肝脏功能损害更轻,作者认为8毫米TIPS支架应优先用于预防静脉曲张再出血。

核心结论

  • 8毫米覆膜支架TIPS分流道功能与10毫米支架相似,但自发性显性肝性脑病风险减半且肝脏功能损害更轻。
  • 作者认为8毫米TIPS支架应优先用于肝硬化患者静脉曲张再出血的预防。

研究设计与样本

  • 随机对照试验,肝硬化患者随机接受8毫米或10毫米覆膜支架TIPS以预防静脉曲张再出血。
  • 8毫米组64例,10毫米组63例;两组中位随访均为27个月。
  • 主要终点为分流道功能障碍,次要终点包括全因再出血、无肝移植生存、复合终点、显性肝性脑病(总体及自发性)及肝脏功能。

主要发现

  • 两年分流道功能障碍率8毫米组16% vs 10毫米组16%(p=0.62),无统计学差异。
  • 两年再出血率8毫米组16% vs 10毫米组17%(p=0.65),无统计学差异。
  • 无肝移植生存率8毫米组95% vs 10毫米组86%(p=0.37),无统计学差异;复合终点p=0.62。
  • 两年内自发性显性肝性脑病发生率8毫米组27% vs 10毫米组43%(p=0.03),风险降低47%。
  • 总体显性肝性脑病仅有边缘性下降;8毫米组肝脏功能损害更轻。

临床怎么用

  • 作者认为8毫米TIPS支架应优先用于肝硬化患者静脉曲张再出血的预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Currently, there are no recommendations in guidelines concerning the preferred diameter of stents for transjugular intrahepatic portosystemic shunt (TIPS), owing to the lack of adequate evidence. We therefore compared 8mm stents with 10mm stents, to evaluate whether 8mm stents would achieve similar shunt function, with less hepatic encephalopathy (HE) and better liver function. METHODS: Cirrhotic patients were randomly assigned to receive TIPS with an 8mm or 10mm covered stent to prevent variceal rebleeding. The primary endpoint was shunt dysfunction. All-cause rebleeding, orthotopic liver transplantation (OLT)-free survival, their composite endpoint, overt HE (overall and spontaneous) and liver function were designated as the secondary endpoints. RESULTS: From July 2012 to January 2014, 64 and 63 patients were allocated to the 8mm and 10mm groups, respectively. During a median follow-up of 27months in both arms, dysfunction rates (16% vs. 16% at two years, p=0.62), two-year rebleeding (16% vs. 17%, p=0.65), OLT-free survival (95% vs. 86%, p=0.37), and the composite endpoint (p=0.62) were not statistically different between the groups. Despite a marginal decrease in overall overt HE, there were significantly fewer spontaneous overt HE incidents in the 8mm group within two years (27% vs. 43%, p=0.03), with a risk reduction of 47%. Notably, patients receiving 8mm stents also developed less hepatic impairment. CONCLUSIONS: TIPS with 8mm covered stents showed similar shunt function to TIPS with 10mm stents, but halved the risk of spontaneous overt HE and reduced hepatic impairment. Therefore, 8mm TIPS stents should be preferred for the prevention of variceal rebleeding in cirrhotic patients. Lay summary: The optimal diameter for transjugular intrahepatic portosystemic shunt (TIPS) remained uncertain. This study showed that TIPS with 8mm covered stents did not compromise shunt patency, or influence the efficacy of variceal rebleeding prevention compared to TIPS with 10mm stents, but reduced the risk of spontaneous overt hepatic encephalopathy and the incidence of severe encephalopathy. Moreover, liver function reserve was also better in the 8mm stents group, suggesting that 8mm TIPS stents should be preferred for the prevention of variceal rebleeding in cirrhotic patients.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang Q, Lv Y, Bai M, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol. 2017. PMID: 28506905. doi:10.1016/j.jhep.2017.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。